Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response during Monetary Reward Anticipation in Drug and Alcohol Dependence

by Murphy, A, Nestor, L.J, McGonigle, J, Paterson, L, Boyapati, V, Ersche, K.D, Flechais, R, Kuchibatla, S, Metastasio, A, Orban, C, Passetti, F, Reed, L, Smith, D, Suckling, J, Taylor, E, Robbins, T.W, Lingford-Hughes, A, Nutt, D.J, Deakin, J.F.W, Elliott, R
Published 2020

The ICCAM platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part B: FMRI description

by McGonigle, J, Murphy, A, Paterson, L.M, Reed, L.J, Nestor, L, Nash, J, Elliott, R, Ersche, K.D, Flechais, R.S.A, Newbould, R, Orban, C, Smith, D.G, Taylor, E.M, Waldman, A.D, Robbins, T.W, Deakin, J.F.W, Nutt, D.J, Lingford-Hughes, A.R, Suckling, J
Published 2020

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery

by Savulich, G, Riccelli, R, Passamonti, L, Correia, M, Deakin, J.F.W, Elliott, R, Flechais, R.S.A, Lingford-Hughes, A.R, McGonigle, J, Murphy, A, Nutt, D.J, Orban, C, Paterson, L.M, Reed, L.J, Smith, D.G, Suckling, J, Tait, R, Taylor, E.M, Sahakian, B.J, Robbins, T.W, Ersche, K.D
Published 2020